High-potency statin and ezetimibe use and mortality in survivors of an acute myocardial infarction: a population-based study

Abstract

Patients switched to a high-potency statin had a significantly reduced mortality compared with simvastatin monotherapy. There was no observed mortality benefit in the ezetimibe group.